{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:12:53Z","timestamp":1790107973223,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jbc.2026.113325","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:32:35Z","timestamp":1783956755000},"page":"113325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The ubiquitin ligase LONRF2 inhibits glycolysis and malignant phenotypes in endometrial cancer through aldolase a degradation"],"prefix":"10.1016","volume":"302","author":[{"given":"Juan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2996-1352","authenticated-orcid":false,"given":"Congjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113325_bib1","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.3390\/ijms24076462","article-title":"New strategies for endometrial cancer detection and management","volume":"24","author":"Paleari","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113325_bib2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S1470-2045(25)00379-1","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial","volume":"26","author":"Post","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2026.113325_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104555","article-title":"First-line treatments for advanced or recurrent endometrial cancer: systematic literature review of clinical evidence","volume":"206","author":"Mirza","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbc.2026.113325_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cac2.12549","article-title":"The regulatory roles and clinical significance of glycolysis in tumor","volume":"44","author":"Qiao","year":"2024","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.jbc.2026.113325_bib5","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113325_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115787","article-title":"The warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation","volume":"24","author":"Alberghina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113325_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s43587-023-00464-4","article-title":"LONRF2 is a protein quality control ubiquitin ligase whose deficiency causes late-onset neurological deficits","volume":"3","author":"Li","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jbc.2026.113325_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174461","article-title":"Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma","volume":"12","author":"Hua","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.113325_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/ol.2022.13600","article-title":"Methylation of CpG island promoters at ZNF625, LONRF2, SDC2 and WDR17 in a patient with numerous non-granular type laterally spreading tumors and colorectal cancer: a case report","volume":"25","author":"Iwaizumi","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2026.113325_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/TACG.S245093","article-title":"Germline sequencing identifies rare variants in Finnish subjects with familial germ cell tumors","volume":"13","author":"Crowgey","year":"2020","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.jbc.2026.113325_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10142-024-01326-x","article-title":"ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis","volume":"24","author":"Meng","year":"2024","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.jbc.2026.113325_bib12","article-title":"MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113325_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41589-019-0323-5","article-title":"S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate","volume":"15","author":"Qin","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.113325_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jb\/mvad021","article-title":"Transcriptomic characterization of Lonrf1 at the single-cell level under pathophysiological conditions","volume":"173","author":"Li","year":"2023","journal-title":"J. Biochem."},{"key":"10.1016\/j.jbc.2026.113325_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/and.13288","article-title":"Disordered APC\/C-mediated cell cycle progression and IGF1\/PI3K\/AKT signalling are the potential basis of sertoli cell-only syndrome","volume":"51","author":"Zhang","year":"2019","journal-title":"Andrologia"},{"key":"10.1016\/j.jbc.2026.113325_bib16","article-title":"Comprehensive analysis of miRNA-Mediated regulatory network and identification of prognosis biomarkers in rectal cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jbc.2026.113325_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.113325_bib18","article-title":"Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance","volume":"13","author":"D'Aprile","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.113325_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s43556-020-00012-1","article-title":"Cancer metabolism and intervention therapy","volume":"2","author":"Zhao","year":"2021","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.jbc.2026.113325_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12916-024-03775-4","article-title":"Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma","volume":"22","author":"Duraj","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.jbc.2026.113325_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","article-title":"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113325_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3846010","article-title":"Comprehensive characterization of the function of metabolic genes and establishment of a prediction model in breast cancer","volume":"2022","author":"Yu","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jbc.2026.113325_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41420-024-02249-z","article-title":"ALDOA contributes to colorectal tumorigenesis and metastasis by targeting YAP","volume":"10","author":"Sun","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jbc.2026.113325_bib24","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/OTT.S290284","article-title":"The ALDOA metabolism pathway as a potential target for regulation of prostate cancer proliferation","volume":"14","author":"Kuang","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.jbc.2026.113325_bib25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","article-title":"The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113325_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/OTT.S518473","article-title":"The expression and clinical significance of ALDOA in breast cancer","volume":"18","author":"Dai","year":"2025","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.jbc.2026.113325_bib27","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1038\/s41598-024-57209-5","article-title":"Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113325_bib28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2147\/CMAR.S157925","article-title":"High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer","volume":"10","author":"Dai","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jbc.2026.113325_bib29","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-18-4080","article-title":"Therapeutic targeting of aldolase A interactions inhibits lung cancer metastasis and prolongs survival","volume":"79","author":"Chang","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113325_bib30","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.apsb.2025.04.018","article-title":"ALKBH3-regulated m(1)A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells","volume":"15","author":"Deng","year":"2025","journal-title":"Acta Pharm. Sin B"},{"key":"10.1016\/j.jbc.2026.113325_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/ijabmr.ijabmr_415_23","article-title":"Scutellarin protects against myocardial ischemia-reperfusion injury by enhancing aerobic glycolysis through miR-34c-5p\/ALDOA axis","volume":"14","author":"Xiang","year":"2024","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.jbc.2026.113325_bib32","article-title":"Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2026.113325_bib33","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.7150\/ijbs.59068","article-title":"Aldolase A enhances intrahepatic cholangiocarcinoma proliferation and invasion through promoting glycolysis","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jbc.2026.113325_bib34","first-page":"905","article-title":"Inflammation and mitochondrial dysfunction in cirrhotic cardiomyopathy: therapeutic implications","volume":"13","author":"Ding","year":"2025","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:50:24Z","timestamp":1790106624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826021976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0021925826021976"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113325","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ubiquitin ligase LONRF2 inhibits glycolysis and malignant phenotypes in endometrial cancer through aldolase a degradation","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113325"}}